Literature DB >> 11284459

Is parenteral methotrexate worth trying?

A Osman, D Mulherin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11284459      PMCID： PMC1753613          DOI： 10.1136/ard.60.4.432

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis.

Authors:  M C Hochberg; J K Tracy; M Hawkins-Holt; R H Flores
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.

Authors:  J Wegrzyn; P Adeleine; P Miossec
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

3.  Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.

Authors:  Eric Senbel; Sonia Tropé; Hélène Herman-Demars; Elena Zinovieva; Agnès Courbeyrette; Pierre Clerson; Yann Fardini; René-Marc Flipo
Journal:  Patient Prefer Adherence       Date:  2021-04-14       Impact factor: 2.711

4.  Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis.

Authors:  Jaime A Pachon; Alan J Kivitz; Kay-Uwe Heuer; Uwe Pichlmeier
Journal:  SAGE Open Med       Date:  2014-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.